Not yet recruiting NCT07112586
Evaluation of Exosomes Injection in Treatment of Male Androgenetic Alopecia: Clinical and Immunohistochemical Study
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Plasma derived exosomes.
- Who it may be relevant to
- Registry conditions: Androgenetic Alopecia. Basic parameters: 18 years — 40 years · Male.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Evaluation of Intradermal Exosome Injection in Treatment of Male Androgenetic Alopecia: A Clinical and Immunohistochemical Study
Overview
Intradermal injection of exosomes in treatment of male androgenetic alopecia, clinically and using a immunohistochemical marker
Interventions
- Drug Plasma derived exosomes
Exosomes derived from patients' plasma, centrifuged at high speeds multiple times
Primary outcome measures
- Terminal to vellus hair ratio improvement [Time frame: One year]
Eligibility criteria
Inclusion criteria
\- Androgenetic Alopecia Grades 1-4
Exclusion criteria
- blood diseases Receiving other treatments History of malignancy or allergic reaction to exosomes
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Ain Shams Univeristy Faculty of medicine — Cairo
Identifiers
NCT: NCT07112586 · Fmasu MD 12 20242025